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High prevalence of nonthrombotic iliac vein
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in pathogenicity
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Purpose:Nonthrombotic iliac vein lesions (NIVL), such as webs and spurs described by May and Thurner, are commonly
found in the asymptomatic general population. However, the clinical syndrome, variously known as May-Thurner
syndrome, Cockett syndrome, or iliac vein compression syndrome, is thought to be a relatively rare contributor of chronic
venous disease (CVD), predominantly affecting the left lower extremity of young women. The present study describes the
much broader disease profile that has emerged with the use of intravascular ultrasound (IVUS) scanning for diagnosis and
analyzes stent placement outcome in two specific NIVL subsets that may offer clues to their pathogenic role.
Methods: Among 4026 patients with CVD symptoms spanning the range of CEAP clinical classes, IVUS examinations
were selectively done in severely symptomatic patients for indications as described. Iliac vein obstructive lesions were
found in 938 limbs of 879 patients; 53% of the limbs had NIVL, 40% were post-thrombotic, and 7% were a combination.
Stents were placed in 332 limbs in 319 patients in two NIVL subsets. The subsets, one with and one without associated
distal limb reflux, were compared. Reflux was left untreated in the first subset.
Results: The median age was 54 years (range, 18 to 90 years). The female–male ratio was 4:1 and the left–right ratio was
3:1. NIVL lesions in the iliac vein occurred at the iliac artery crossing (proximal lesion) and also at the hypogastric artery
crossing (distal lesion), a new IVUS finding. Venography was only 66% sensitive, with 34% of venograms appearing
“normal.” IVUS had a diagnostic sensitivity of>90%. The cumulative results observed at 2.5 years after stent placement
in theNIVL subsets with reflux andwithout reflux, respectively, were complete relief of pain 82% and 77%, complete relief
of swelling 47% and 53%, complete stasis ulcer healing 67% and 76%, and overall clinical relief outcome 75% and 79%.
These results are nearly identical between the two subsets even though distal reflux remained uncorrected in the NIVL
plus reflux subset.
Conclusions: NIVL has high prevalence and a broad demographic spectrum in patients with CVD. Similar lesions in the
asymptomatic general population may be permissive of future development of CVD. Stent placement alone, without
correction of associated reflux, often provides relief. ( J Vasc Surg 2006;44:136-44.)Virchow1 attributed the increased left-sided predilec-
tion of deep venous thrombosis to left iliac vein compres-
sion by the crossing artery. In 1908, McMurrich2 first
reported the presence of web-like intrinsic intraluminal
lesions in 33% of 107 unselected cadavers. Subsequent
large autopsy series3–5 confirmed the surprisingly high
prevalence of the lesion in the asymptomatic general pop-
ulation. There is disagreement if the lesions are ontogenic
at embryonic venous fusion sites6 or traumatic from the
pulsations of the overlying artery. A post-thrombotic etiol-
ogy appears to be ruled out,4,5 even though instances of
secondary thrombosis apparently induced by the lesions are
well documented.7,8
Corrosion cast and venographic studies suggest that
the incidence of extrinsic compressive lesions may be even
more pervasive than intrinsic lesions.5,7 Recent imaging
data9 indicate that compression of the left iliac vein at the
arterial crossover pointmay be present in 66% of the general
population without any venous symptoms. Because imag-
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136ing methods, including intravascular ultrasound (IVUS),
cannot differentiate intrinsic from extrinsic lesions with
sufficient clarity, the generic term nonthrombotic iliac vein
lesion (NIVL) is used throughout this report to be inclusive
of both types of lesions.
Despite the widespread prevalence of the lesion in the
general population, the clinical syndrome (iliac vein com-
pression syndrome, May-Thurner syndrome, or Cockett
syndrome) is thought to be a relatively rare cause of chronic
venous disease (CVD), responsible for only 1% to 5% of
cases.10 The diagnosis is often established by venography in
selected cases fitting the classic clinical profile described by
Cockett and Thomas11 of severe left limb symptoms of pain
and swelling in young women. The diagnostic sensitivity of
venography for nonthrombotic iliac vein type lesions is
known to be poor.5 Liberal use of the more sensitive
IVUS12,13 yields a more diverse picture of the syndrome
than previously appreciated; particularly, we found the
incidence of nonthrombotic iliac vein type lesions to be
very high in symptomatic CVD cases. The question then
arises if these lesions are pathogenic in CVD or simply
incidental findings. Outcome data after successful stent
correction of the lesions in two specific subsets described
below suggests that NIVLsmay play a permissive role in the
development of CVD.
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From 1996 to 2004, 4026 new patients with CVD
symptoms spanning all CEAP14 clinical classes were evalu-
ated. Patients with nonvenous causes of limb symptoms
were excluded. Detailed investigations and later IVUS ex-
aminations were selectively carried out in severely symp-
tomatic patients for indications as outlined below. Signifi-
cant proximal venous outflow obstruction was found by
IVUS examination in 938 limbs (879 patients), which were
treated by stent placement. The etiology of obstruction was
classified as NIVL in 493 limbs (53%), as post-thrombotic
disease (PTS) in 377 limbs (40%), and as mixed in 68 limbs
(7%) by distinctive IVUS appearance (see later) supple-
mented by ancillary clinical data, such as prior deep venous
thrombosis, and venographic and duplex features. The
nonthrombotic–thrombotic disease ratio was 5:4. This
study pertains only to limbs with NIVL; limbs with PTS
lesions were excluded. Limbs with features of both NIVL
and PTS were assumed to be primary NIVL complicated by
thrombosis and were excluded as well because they behave
like other PTS cases in clinical features and outcome.
All 493 limbs underwent stent placement, some with
additional procedures for treatment of reflux, typically per-
cutaneous saphenous ablation. The 110 limbs in the latter
combined procedure group and 51 other limbs that devel-
oped significant in-stent restenosis (20% stenosis) were
excluded from analysis as the aim was to compare the
outcome of successfully corrected NIVLs in the two tar-
geted subsets unadulterated by concurrent procedures or
impaired stent patency.
Correction of NIVLs by stent treatment may offer clues
to their pathogenic role and reflected in the differential
outcome in the two subsets. This study therefore focuses on
a cohort of 332 of 493 limbs with NIVLs in 319 patients
treated by stent placement alone that were functioning well
during the observation period. These limbs were divided
into two subsets: (1) NIVL limbs with concurrent superfi-
cial or deep reflux, or both, that were stented with the reflux
component left untreated during the observation period (n
 151) and (2) limbs with NIVL alone, without associated
reflux, that were also stented (n  181).
Details of clinical presentation, workup, indications,
stent technique, and results of treatment have been pre-
sented at length elsewhere15–17 and will not be repeated
here except briefly in context.
Investigations. In general, detailed investigations
were performed only in CEAP14 clinical severity class 3,
that is, limbs with significant (grade 3) edema, stasis skin
changes, ulceration, or a combination. Exceptions were
limbs with recurrent cellulitis or limbs with severe diffuse
venous pain that were also considered regardless of CEAP
class (ie, CEAP 0 to 2were also considered). Diffuse venous
pain means generalized orthostatic or claudication type but
not pain localized only to varices. Pain was severe if 5 on
an analogue scale or required daily use of nonsteroidal or
narcotic medication for relief. Pain is not adequately cov-
ered by CEAP classification. Some patients in C3 withswelling and C4 clinical class with hyperpigmentation have
little pain, do not rate their symptoms as severe, and are not
candidates for a stent procedure. Conversely, even minimal
swelling could be disabling if painful, particularly in elderly
patients who are unable to apply compression because of
frailty or arthritis.
The patients who were selected underwent a compre-
hensive set of venous laboratory tests, including duplex
scan, ambulatory venous pressure measurement (% drop,
venous filling time [VFT]), air plethysmography venous
filling index (VFI90) and contrast studies. A valve closure
time0.5 seconds on duplex scan was defined as reflux and
graded by reflux segment score,18 VFT, and VFI90. Inves-
tigations related to iliac vein obstruction were duplex scan-
ning (2 phasicity),19 arm/foot pressure test,19 and trans-
femoral venography with measurement of exercise femoral
pressures.20 The latter tests have varying degrees of sensi-
tivity and specificity. They are helpful when results are
positive but are not definitive. IVUS is the gold standard to
detect iliac vein obstruction.13
IVUS examination and stent placement. IVUS ex-
amination and possible concurrent stent placement were
considered in patients who had severe symptoms interfer-
ing with work or daily living and had failed conservative
therapy. Patients undergoing IVUS fell into one of two
broad categories:
1. Iliac vein pathology was suspected (estimated 80% of
limbs) from one or more of the investigations, whether
associated with significant distal reflux or not, and
2. Results of investigations for iliac vein obstruction were
negative (estimated 20% of limbs) but clinically sus-
pected because detected distal reflux was either minimal
(eg, single segment reflux) or altogether absent in the
context of severe symptoms.
Technique. The IVUS system (EndoSonics, Pleasan-
ton, Calif or Sonicath, Boston Scientific, Natick, Mass)
used a 6F transducer-mounted catheter threaded on a
0.32-inch guidewire (Glidewire, Terumo, Somerset, NJ)
inserted percutaneously. The iliac venous segment was
assessed by on-table single-plane transfemoral venography,
IVUS, and finally, balloon sizing (14- to 16-mm balloon
inflated to 1 atm pressure to detect waisting) because
lesions were occasionally impervious to even IVUS.
NIVLs and PTS lesions have distinctive IVUS features
and are easily differentiated. PTS lesions are segmental,
involving at least one entire segment (eg, common iliac
vein) and often adjacent segments as well (eg, external iliac
and femoral veins), because the thrombus typically propa-
gates to the next large tributary. PTS lesions are irregular,
multiple, and diffuse with wall fibrosis and lumen stenosis
in the entire vein segment; trabeculae may be present. In
contrast, NIVLs are subsegmental and focal (2 cm), they
occur at or near arterial crossover points near the upper or
lower ends of the vein segment, and wall thickness and
lumen size of the rest of the vein segment are normal.
Lesions of mixed appearance (7%) were classified as NIVL-
induced PTS and excluded.
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dilated and always stented with a 14- to 16-mm Wallstent
(Boston Scientific) because restenosis was universal other-
wise.15,17 On venography, the degree of obstruction could
be recorded as the diameter of the stenotic area/the diam-
eter of the normal vein below the stenosis 100 (%). On
IVUS, the built-in software program allowed the actual
transverse lumen area to be outlined and measured, giving
an absolute value (cm2) and a comparison with the area
below the stenosis.
Clinical follow-up. Patients were treated on an out-
patient basis (23-hour admission). Those patients compli-
ant with compression devices were encouraged to attempt
abandoning them after 3 weeks postoperatively, as com-
pressive regimens were a quality-of-life issue with many.
Noncompliant patients were not fitted with new stockings.
Patients were examined at 6 weeks, 3 months, 6 to 9
months after stent placement, and at yearly intervals there-
after. Venography or duplex ultrasound scans, or both,
were used to assess stent patency during the first 6 months
and then annually.
The degree of swelling was assessed by physical exami-
nation (grade 0, none; grade 1, pitting, not obvious; grade
2, ankle edema; and grade 3, obvious swelling involving the
limb). The level of pain was measured by the visual ana-
logue scale method.21 Swelling and pain outcome compar-
isons, as shown in cumulative graphs, are based on com-
plete relief (grade 0 swelling and 0 level of pain) because
they provide clear clinical end points. Ulcer healing was
defined as complete epithelialization. Overall outcome was
graded after reporting standards14 as follows: grade 3,
excellent result, asymptomatic; grade 2, good result with
mild residual symptoms; grade 1, some improvement with
substantial residual symptoms; grade 0, no relief, un-
changed from before.
Data analysis. Clinical data were entered prospec-
tively into a time-stamped electronic medical records pro-
gram for retrospective analysis. The commercially available
statistical program Graph Pad Prism 3.0 (GraphPad Soft-
ware, San Diego, Calif) for Windows (Microsoft, Red-
mond, Wash) was used for statistical analysis. Nonparamet-
ric Wilcoxon rank sum test for unpaired data and the 2 test
were used to compare groups as appropriate. Cumulative
curves using the Kaplan-Meier method were used to ana-
lyze and compare clinical outcome. Log-rank test was used
to assess significance between cumulative curves. P  .05
was considered significant.
RESULTS
The 319 patients in the two subsets included in this
study were a median age of 54 years (range, 18 to 90 years)
(Fig 1). The female–male ratio was 4:1. Bilateral stents were
placed in 13 patients (4%) resulting in 332 treated limbs.
The left–right limb ratio was 3:1. Specific characteristics of
the two subsets with and without reflux are detailed in
Table I.
The clinical presentation spanned the spectrum of C
classification: C1, 1 (0.3%); C2, 34 (10%); C3, 183 (55%);C4, 69 (21%); C5, 6 (2%); and C6, 39 (12%). The 35
patients in C1 and C2 had severe pain. Patients had varying
combinations of pain, swelling, or stasis skin changes. Pain
was absent in 27% and 22%, and swelling was absent in 22%
and 17% of the limbs preoperatively in the two subsets with
and without reflux, respectively. The distribution of reflux
in the NIVL plus reflux subset was superficial reflux, 32%;
deep reflux, 20%; and combined superficial and deep reflux,
38%. Perforators (4 mm) were present in 11%: 1% with
deep reflux, 4% with superficial reflux, and 6% with super-
ficial and deep reflux. Axial deep reflux to the calf was
present in 30% of the limbs with deep reflux. Median reflux
segment score was 2 (range, 1 to 7). VFT was significantly
shorter and VFI90 greater in the NIVL plus reflux subset
(Table I).
Distinct venographic stenosis in the frontal projection
at the proximal (common iliac vein) site, the iliac artery
crossover point, was present in only 23% of limbs. In
another 20% of limbs, less obvious signs such as contrast
translucency, lumen broadening or pancaking, or contrast
irregularities suspicious of intraluminal webs or strictures,
or a combination, were present (Fig 2). Axial, transpelvic,
or ascending lumbar collaterals were present in 36% of
limbs. Venography with one or more of the above features
was abnormal in 66% of limbs. In the remaining limbs
(34%), single-plane venograms were interpreted as “nor-
mal.”
IVUS findings. A single proximal NIVL was present
in the common iliac vein in 36% of limbs (n  255).
[Accurate record of distribution of proximal and distal
lesions started only after May 2001.] In 8% of cases, a single
distal NIVL was found at or near the internal iliac vein
junction; in 46% the distal lesion occurred with the proxi-
mal lesion. The proximal NIVL was typically very focal (1
cm) on the left side and was located at the iliac-caval
junction; the right proximal NIVL was less focal (2 cm)
and was located 1- to 2-cm distal to the iliac-caval junction.
The proximal NIVL was three times more frequently ob-
Fig 1. Age distribution of 319 patients with nonthrombotic iliac
vein lesions. The median age was 54.served on the left side, whereas the distal NIVL was equally
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stenosis (proximal or distal), as measured by IVUS, was
0.58 cm2 (range, 0.02 to 2.00 cm2; normal, 1.5 cm2)
representing approximately 70% stenosis. These data in-
clude some lesions (5%) with “normal” IVUS luminal
area that were detected only by balloon sizing. These
lesions were graded as zero stenosis in calculation of IVUS
stenoses (Table I). Most NIVLs were “soft” compared with
PTS or arterial lesions, with waisting of the balloon often
relieved at 2 atm.
Clinical results. There was no operative (30-day) mor-
tality. Postintervention clinical evaluation was available in 90%
of patients (298/332), with follow-up to 7 years (median, 10
Fig 2. Variable venographic appearance of nonthrombo
contrast translucency appearing as a filling defect (arrow)
(arrow). Right, the venogram appears entirely normal
However, an intravascular ultrasound (IVUS) scan show
IVUS catheter (arrow); “a” denotes adjacent artery. The
IVUS found the NIVL.
Table. Demographics, intravascular ultrasound findings an
nonthrombotic iliac vein lesions with and without venous
Parameter N
Age, years
Female–male ratio
Left–right limb ratio
IVUS degree of stenosis (%)
Stenotic area (cm2)
Ambulatory venous pressure
% drop
Venous filling time (s)
APG:VFI90 (mL/s)
Hand-foot pressure differential (mm Hg)
Dorsal foot hyperemia pressure differential (mm Hg)
NIVL, Nonthrombotic iliac vein lesions; IVUS, intravascular ultrasound; A
Data are presented as ratios or median (range).
*P .01.
†Not significant.
‡P  .001.months; range, 1 to 85months). The data set was adequate toconstruct cumulative curves extending to 2.5 years. Therewas
a substantial, statistically significant symptom improvement in
the entire study group, but also in each subset after stent
placement, despite presence of untreated venous reflux in one
subset. The data showing cumulative rate of symptom relief,
as presented in Figs 3 and 4, represent only limbs that had
preoperative pain or swelling, respectively, for the two subsets.
Limbs that did not have the specific symptom preoperatively
(see earlier) are not included. The curves are nearly identical,
with no statistical difference (log-rank test,P0.17 and0.62,
respectively). In NIVL with reflux and NIVL without reflux
subsets, respectively, 82% and 77% were completely freed of
swelling, and 47% and 53% were completely freed of pain at
ac vein lesions (NIVLs). Left, “Classic” appearance with
dle, Broadening (pancaking) of the vein with collaterals
bout a third of cases. Note the absence of collaterals.
ight lesion (inset) with the lumen not larger than the 6F
w in the venogram points to the general area where the
einterventional hemodynamics in stented limbs with
with reflux (n  151) NIVLs without reflux (n  181)
56 (20-85) 51 (18-90)*
0:36 (3.1:1) 146:31 (4.7:1)†
5:46 (2.3:1) 136/45 (3:1)†
70 (0-95) 70 (0-100)†
0.66 (0.15-2.00) 0.53 (0.02-1.65)*
77 (0-97) 77 (0-99)†
23 (2-132) 44 (0-165)‡
2 (0-12.3) 0.9 (0.0-6.0)‡
1 (0-8) 1 (0-10)†
6 (0-26) 5 (0-23)†
r plethysmograph.tic ili
.Mid
in a
ed a t
arrod pr
reflux
IVLs
11
10
PG, ai2.5 years.
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reflux, 10 limbs without). Thirty-four limbs (87%) were
followed during a median 19 months (range, 1 to 84
months) after stent placement. The cumulative rates of
limbs with completely healed ulcers for the two subsets
with and without reflux were 67% and 76% at 2.5 years (Fig
5), with no significant difference (P  .34 by log-rank test).
Only 12 of the 34 ulcer patients (healed 8 and unhealed 4)
reported using compression devices, which appears not to
Fig 3. Pain relief after stent placement alone in nonthrombotic
iliac vein lesion (NIVL) subsets with and without reflux. The
cumulative curves represent limbs (%) with complete relief of pain.
Only limbs that had preoperative pain are shown. At 2.5 years, 82%
and 77% of limbs in the two subsets, respectively, were totally free
of pain. There is no statistical difference between the curves. Limbs
at risk at various time intervals for each subset are shown at the
bottom of the graph (all SEM 10%).
Fig 4. Swelling relief following stent placement alone in non-
thrombotic iliac vein lesion (NIVL) subsets with and without
reflux. Only limbs with preoperative swelling are shown. The
cumulative curves represent limbs (%) with complete relief of
swelling. At 2.5 years, 47% and 53% of limbs in the two subsets,
respectively, were totally free of swelling. There is no statistical
difference between the curves. Limbs at risk at various time inter-
vals for each subset are shown at the bottom of the graph (all SEM
10%).have been a major factor in ulcer healing. At 2.5 years, thecumulative overall good or excellent clinical outcomes
(grades 2 and 3 as per reporting standards)14 for patients
with and without reflux were similar at 75% and 79% (P 
.31 by log-rank test) (Fig 6).
DISCUSSION
With IVUS, a newer clinical profile of NIVL has
emerged: the disease is dominant but not exclusive to left
lower limbs of young women. Clearly, no patient should be
excluded from consideration of the syndrome based on age,
sex, bilaterality, or involvement of the right side. Leg
Fig 5. Cumulative complete ulcer healing following stent place-
ment in nonthrombotic iliac vein lesion (NIVL) subsets with and
without reflux. Reflux was not corrected in the latter subset, yet
67% of ulcers remained completely healed at 2.5 years. Ulcer
healing was 76% in the subset without reflux at 2.5 years. There is
no statistical difference between the curves. Limbs at risk at various
time intervals for each subset are shown at the bottom of the graph
(SEM 10% solid line; SEM 10% hashed line).
Fig 6. Overall symptom relief following stent placement in non-
thrombotic iliac vein lesion (NIVL) subsets with and without
reflux. Each curve (cumulative) represents limbs with grade 3 or 2
(excellent or good) outcomes for the specific subset. The curves are
nearly identical. Limbs at risk for each subset at various time
intervals are shown at the bottom of the graph (all SEM 10%).swelling in older patients is often dismissed as due to cardiac
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adequate venous investigation. Clinical benefit and quality-
of-life improvement in this age group from a low-risk stent
procedure can be impressive. Many in this series were
geriatric, and the oldest patient was 90 years old. Some
younger patients were symptomatic in their early teens, but
stent placement was deferred until the vasculature reached
adult size.
The right iliac artery always crosses the left common
iliac vein abruptly and is related to the classic proximal
left NIVL. Subsequent course of the right iliac artery is
variable, with variable compression points as detailed by
Negus et al.5 It crosses the right common iliac vein in
only 22% (minority pattern) as shown in Fig 7, coursing
lazily over a longer length of the vein. The long overlay
may be variably responsible for either the proximal or
distal NIVL, or both. In 75% (majority pattern), the
right iliac artery crosses the right iliac vein more abruptly
and at a more distal point over or near the external iliac
vein level (Fig 7 inset), in which case, it may induce right
distal NIVL but will not be a factor in right proximal
NIVL.5 The left distal lesion may be related to the
crossing of the vein by the left hypogastric artery. The
right hypogastric artery does not cross the iliac vein at all
or only partially either in the majority or the minority
pattern and therefore does not have a role in right distal
Fig 7. The pathologic anatomy of a nonthrombotic iliac vein
lesion (NIVL). The classic left-sided proximal lesion is related to
abrupt crossing of the left iliac vein by the right iliac artery. The
subsequent course of the right iliac artery is variable (see text). The
minority pattern (22%) is shown in the large drawing. Coursing
lazily across the vein, the right iliac artery may be related to the
proximal or distal NIVL, or both. In the majority pattern (preva-
lent in 75%, shown in the inset), the right iliac artery crosses the
right common iliac vein more abruptly, but lower down at or near
the external iliac vein level, inducing distal right NIVL but will not
be a factor in proximal right NIVL. The left hypogastric artery
crossing may be related to left distal NIVL. The hypogastric veins
have been omitted to reduce clutter.NIVLs. Thus, proclivity for NIVLs of all locations, rightor left, proximal or distal, exists only in the minority
pattern; the majority pattern favors all except the right
proximal NIVL. These anatomic variations may explain
why proximal NIVLs occur much more frequently on the
left side than on the right side, why the left lesion is focal
and the right less so, and why the distal NIVL occurs
equally on either side.
The poor diagnostic sensitivity of venography was well
documented by Negus et al,5 and venographic data pre-
sented here are strikingly similar. Of practical importance is
that a third to half of the cases can be missed if frontal
projection venograms alone are relied on for diagnosis.
Diagnostic sensitivity may be increased by special projec-
tions, a cumbersome process that increases radiation expo-
sure (Fig 8).
The frequent absence of venographic collaterals was
noted by Negus et al.5 Collaterals may be absent even in
high-grade obstructions.19 Very little is known about ve-
nous collateral development. Collateral development prob-
ably requires a higher degree of stenosis than is necessary to
generate symptoms of pain and swelling.22 IVUS has a
diagnostic sensitivity of 90% and is indispensable in suc-
cessful stent placement.13,15,17,22,23
The pathogenic role of NIVL in chronic venous
disease. The left–right ratio of the clinical syndrome
roughly correlates with the left–right distribution of
NIVLs, suggesting a connection. In our own practice, we
have noticed that the left lower limb may be symptomatic
and the right side asymptomatic, even when ambulatory
venous pressure is worse on the right side (unpublished
data). The excellent therapeutic response to stent place-
ment indicates that the NIVL contributes in some way to
CVD pathology. Of particular interest is the subset with
NIVLs with reflux that became symptom–free with stent
correction of the NIVL alone, even when the reflux com-
ponent remained uncorrected. Notably, 67% of stasis ulcers
in this subset also healed and remained healed at 2.5 years,
ruling out a placebo effect. CVD symptoms, including
stasis ulcers, are not due to reflux alone; the NIVL plays a
role in ways yet to be understood. Ulcers also occur in
NIVLs without reflux, although the incidence is higher
with reflux.
The high prevalence and pathologic role of NIVLs in
symptomatic CVD patients have to be squared with the
frequent prevalence of NIVLs in the asymptomatic general
population. The latter fact has raised scepticism that the
NIVL is even pathogenic,9 with the suggestion that it
should be viewed as a “normal” anatomic variant. Why do
these lesions become symptomatic in some but remain
silent in most?
These apparent contradictions can be resolved if the
NIVL is viewed as a permissive condition predisposing to
the development of CVD. Permissive conditions are pa-
thologies that may remain variably silent until additional
insult or pathology is superimposed. Interruption of major
venous pathways cannot be considered a “normal variant,”
only clinically asymptomatic. There is extensive literature
on pathologic and iatrogenic major venous interruptions.
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Symptom expression would depend on if the interruption is
acute or chronic,28 partial or total,29,30 peripheral or cen-
tral, and on the pace and extent of collateralization.26,31,32
Concomitant reflux or other pathology usually renders the
limb symptomatic.26,31 Hemodynamic abnormalities may
be present even in the absence of symptoms.31,32 Numer-
ous reports have been published of silent congenital or
acquired inferior vena cava occlusions discovered inciden-
tally on imaging studies that become symptomatic with the
onset of distal thrombosis.28,33,34
It is therefore not surprising that many NIVL obstruc-
tions remain asymptomatic, because it probably is a slowly
progressive condition. Additional insult or pathology such
as trauma, cellulitis, distal thrombosis, secondary lymphatic
exhaustion,35 or commonly, reflux, may render the extrem-
ity symptomatic. Fluid balance in the limb is on the edge
during orthostasis, even in healthy individuals.36 In the
elderly, atherosclerosis of the overlying artery, venosclero-
sis, decreasing mobility, and leg dependency, or other
comorbid conditions predisposing to pedal edema, may be
contributory factors in symptom expression.
In others, the precipitating cause for symptoms is ob-
scure. This is in line with numerous other known permissive
conditions that may remain variably silent but predispose to
secondary pathology and symptoms with additional insult.
Some well-known examples include gastroesophageal re-
flux disease and asthma, ureteric reflux and pyelonephritis,
patent foramen ovale and embolic stroke, cricopharyngeal
spasm and Zenker’s diverticulum, esophageal reflux and
cancer, obesity and diabetes, diabetes and neuropathy,
middle lobe syndrome and pneumonia, and carotid stenosis
and neurologic sequelae. The general principle in these
complex pathologies is to treat the permissive condition
Fig 8. The proximal lesion is coronal and the distal lesion
anterior to the posterior rather than transversely. Note t
the tube is rotated frommidline to lateral in the coronal p
lesion is spiral, often giving a corkscrew appearance.first, which alone may provide relief, and to prevent recur-rence. Correction of secondary pathology may be required
only in recalcitrant and advanced cases.
In this series, 75% of limbs with NIVLs and concurrent
reflux experienced a good or excellent outcome with stent
placement alone, even when the reflux component, severe
in many, was uncorrected. These results support the con-
cept that the NIVL plays a permissive role in the genesis of
CVD symptoms. It seems highly unlikely that the good
outcome could be attributed to enhanced postoperative
stocking use, because patients were encouraged to abandon
stockings after stent placement. NIVLs are ubiquitous in
CVD with severe symptoms, and liberal use of IVUS and
stent correction when detected is recommended. Even
patients with significant distal reflux benefit, thus avoiding
or postponing open reflux corrective procedures, which are
not precluded if the stents were to fail later.
When symptoms recur after initial remission following
stent placement, our current practice is to perform an IVUS
to ensure proper stent function. Often, stent malfunction is
found, such as distal migration of the stent with recurrence
of the lesion at the iliac-caval junction, missed or incom-
plete treatment of the distal lesion, or less commonly,
in-stent stenoses. When corrected, the patient is usually
returned to the status of symptom remission. These bene-
ficial results of reinterventions are not shown in the cumu-
lative curves of the results presented here, because only the
results of primary interventions are displayed, and limbs
with subsequent reinterventions were censored at the time
of symptom recurrence. Valve reconstruction has been
required in only a handful of cases (5%) during the
reported observation period for persistent recurrent symp-
toms.
An alternative explanation for the observations pre-
sented here is to consider NIVLs and distal reflux as a
ten sagittal as the hypogastric artery crosses the vein from
fferential appearance and disappearance of the lesions as
0° (Left), 45° (Middle), and 60° (Right). The proximalis of
he di
lane:continuum in progressive hemodynamic deterioration of
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 1 Raju and Neglen 143the venous system; symptomatic decompensation occurs
when the hemodynamics cross a certain critical threshold.
However, no connection between NIVLs and distal reflux
has yet been established. Furthermore, the hemodynamics
of the respective pathologies are poorly understood, and
the relevant metrics even less, to offer tangible support for
the latter concept at this time.
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